English
Jump into the intersection of microbiology and sepsis. In this workshop, recorded at the 29th European Congress of Clinical Microbiology & Infectious Diseases, Jeannine Holden, M.D., MBA., covers sepsis comprehensively, from sepsis etiology, to risk assessment criteria, to current diagnostic guidelines. Dr. Holden will discuss the importance of using hematology assays to assess the risk of sepsis. Specifically, familiarize yourself with the latest hematologic findings in sepsis and gain insights that will help your institution achieve early sepsis identification for more effective antibiotic administration.
After viewing this webinar, you will be able to:
- Know what sepsis is
- Learn what laboratory findings support early sepsis identification
- Discover hematologic findings in sepsis, including the importance of monocyte distribution width in sepsis diagnosis
Presenter: Jeannine Holden, M.D., MBA
Dr. Holden is vice president of medical and scientific affairs and chief medical officer for Beckman Coulter Diagnostics. Leveraging her deep experience in diagnostics, laboratory management, education and regulatory and reimbursement strategy, she is responsible for medical oversight of Beckman Coulter. She also manages a team of physicians and scientists who support innovation and assay implementation.
Prior to joining the organization in 2013, she served as associate professor and director of hematopathology and flow cytometry at Emory University School of Medicine in Atlanta, Georgia. During her tenure there, Dr. Holden built and managed the hematopathology reference laboratory, providing expert consultation service in microscopy, flow cytometric immunophenotyping, fluorescence in situ hybridization, cytogenetics and molecular diagnostics. She directed Emory’s hematopathology fellowship program and is recognized nationally and internationally as an educator. Her peer-reviewed publications focus on improved diagnostic accuracy and healthcare reimbursement.
Dr. Holden received her undergraduate degree from University of Virginia, her M.D. from Emory University School of Medicine—where she also completed training in anatomic and clinical pathology and hematopathology—and her MBA from Georgia Institute of Technology.
